Capricor Therapeutics
CAPR
#7991
Rank
โ‚ฌ0.24 B
Marketcap
5,44ย โ‚ฌ
Share price
-4.36%
Change (1 day)
-61.47%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -โ‚ฌ72.31 Million

According to Capricor Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ11.13 Million. In 2024 the company made an earning of -โ‚ฌ34.62 Million a decrease over its 2023 earnings that were of -โ‚ฌ19.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ72.31 Million108.9%
2024 -โ‚ฌ34.62 Million81.57%
2023 -โ‚ฌ19.07 Million-23.2%
2022 -โ‚ฌ24.83 Million44.93%
2021 -โ‚ฌ17.13 Million46.61%
2020 -โ‚ฌ11.69 Million78.71%
2019 -โ‚ฌ6.54 Million-49.7%
2018 -โ‚ฌ13 Million-724.78%
2017 โ‚ฌ2.07 M-112.93%
2016 -โ‚ฌ16.09 Million46.27%
2015 -โ‚ฌ11 Million106.82%
2014 -โ‚ฌ5.32 Million-48.41%
2013 -โ‚ฌ10.31 Million977.23%
2012 -โ‚ฌ0.96 Million-77.11%
2011 -โ‚ฌ4.18 Million-22.35%
2010 -โ‚ฌ5.39 Million-20.17%
2009 -โ‚ฌ6.75 Million-41.17%
2008 -โ‚ฌ11.47 Million41.05%
2007 -โ‚ฌ8.13 Million1098.87%
2006 -โ‚ฌ0.68 Million4101.55%
2005 -โ‚ฌ0.02 Million-0.97%
2004 -โ‚ฌ0.02 Million17.87%
2003 -โ‚ฌ0.02 Million3.66%
2002 -โ‚ฌ0.02 Million-30.11%
2001 -โ‚ฌ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cytokinetics
CYTK
-โ‚ฌ0.65 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚ฌ14.8 Million-78.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.70 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.49 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.22 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ8.12 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA